Tag Archives: benchmarking

Creating and Maintaining a Strategic KOL Management and Engagement System

Across the pharmaceutical sector, regulatory and access issues have reshaped interactions with Key Opinion Leaders (KOLs). And with KOL interactions affecting everything from clinical development to product launch, the issue of strategically managing these critical exchanges looms large for small

Role of Medical Affairs Increasing in Oncology Launch

The Medical Affairs function plays a vital role in a host of oncology activities, including identification and engagement of Key Thought Leaders to guidance of commercial strategies and launch resources management. It is becoming increasingly apparent that a successful launch

Frustrations of a Pharmaceutical Market Researcher…

Not that long ago, I was updating a key research project here at Best Practices; and as usual, I was waiting on approval from our research manager. The approval delay made me agitated, but not nearly as much as when

Best Practices Hosts 7th Digital Marketing Consortium Roundtable

Author:

Best Practices hosted our 7th Digital Marketing Consortium Roundtable on Thursday, July 23. The topic of the virtual conference was “Key Trends & Innovative Activities in 2015 Biopharma Digital Marketing.” The roundtable brought together executives from 8 leading pharmaceutical companies

Overcoming Regulatory Risks and Gaining Critical Insights through Social Media Listening

Author:

The pharmaceutical industry as a whole has struggled to delve into the social media world. The main reason for this is due to regulatory restrictions, with organizations fearful to engage in online conversations with patients due to the perceived high

Best Practices Hosting 6th Medical Affairs Consortium on HEOR

Author:

Best Practices will be hosting the sixth roundtable of our Medical Affairs Consortium on Thursday (May 28th) from 11:00AM-12:30PM (EST) via a virtual roundtable to discuss “Medical Affairs’ Role in Health Economics & Outcomes Research.” This is the final roundtable

One Way to Please the Boss (& the Boss’s Boss): Crafting Highly Effective Executive Briefs

A quick peek behind the curtain at the Best Practices Research Center and a Most Interesting Case that recently landed on my desk. We are a consulting firm whose clients work mainly in the pharma and biotech sector.  As a

Patient Centricity Has Arrived. Bigger Question: Where Is It Headed?

Patients have always been on pharma’s radar, though it has historically been as a target of marketing (the most obvious being Direct to Consumer (DTC) advertising).  But now under the banner of Patient Centricity, pharma companies large and small are

Six Digital Marketing Trends that will Affect the Pharmaceutical Industry in 2015

The pharma sector has long trailed more consumer and tech-savvy industries in the uptake of digital media for marketing their products. Uncertainty around industry regulations and how to safely interact with patients and physicians have prevented many large pharma organizations

Top Trends in 2015 – Is Your Organization Prepared?

Author:

2015 is here & with the New Year comes many new trends and topics of discussion. With the increasing importance of payers and high demand on evidence-based information, it is clear that there are many shifts happening in the pharmaceutical,

Internal Communication Commandments to Live By

In order to improve an organization as a whole, it is critical to improve internal corporate communications. Best Practices, LLC’s work highlights how companies deliver their internal messages and find the proper balance between informing and educating employees. We have seen companies

Best Practices’ Hosting Medical Affairs Consortium Roundtable Thursday, Nov. 6

Author:

Best Practices designed the Medical Affairs Consortium to provide Medical Affairs leaders with a forum for sharing insights about the key challenges they face. The consortium has developed a mechanism for creating and sharing solutions through three virtual roundtable discussions

Pharma Companies Feeling the Heat From the Sunshine Act

Author:

Last week marked the release of the initial data from the Sunshine Act law of the Affordable Care Act, which had been dreaded by many health care professionals and pharmaceutical and medical device executives. So, for the past few years,

Thou Shalt Build Credibility But Plan for the Worst

Author:

As pharma companies plan for the launch of new products, much of the discussion centers around how to position a new drug or device to the rest of the world. Still, much of that same planning can be internalized and